Literature DB >> 6171074

Softening of drusen and subretinal neovascularization.

S H Sarks, D Van Driel, L Maxwell, M Killingsworth.   

Abstract

On the basis of clinico-pathological examination, drusen were divided into hard and soft. A few small, hard drusen with a hyaline composition were found in 50 per cent of the normal aged eyes examined. The appearance of drusen of softer consistency often heralded the onset of senile macular degeneration. Soft drusen resulted either from the breakdown of the hyaline content of hard drusen or from the focal aggregation into mounds of membranous debris which accumulated as a widespread shallow layer between the basement membrane of the pigment epithelium and Bruch's membrane. Softening of drusen was most evident when the retinal pigment epithelium demonstrated the greatest proliferative activity, with migration of cells into the retina and the formation of the basal laminar deposit. It was at this stage that subretinal neovascularization was first detected. A patient in whom the gradual development of small soft drusen and an associated pigmentary disturbance was followed by subretinal new vessel formation is reported. The eye was subsequently found to have five separate breaks in Bruch's membrane and the ultrastructural findings are described.

Entities:  

Mesh:

Year:  1980        PMID: 6171074

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  42 in total

1.  Microstructure of subretinal drusenoid deposits revealed by adaptive optics imaging.

Authors:  Alexander Meadway; Xiaolin Wang; Christine A Curcio; Yuhua Zhang
Journal:  Biomed Opt Express       Date:  2014-02-12       Impact factor: 3.732

Review 2.  Role of Lipids in Retinal Vascular and Macular Disorders.

Authors:  Gunjan Prakash; Rachit Agrawal; Tanie Natung
Journal:  Indian J Clin Biochem       Date:  2016-03-08

3.  Adhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation study.

Authors:  Abbas Shirinifard; James Alexander Glazier; Maciej Swat; J Scott Gens; Fereydoon Family; Yi Jiang; Hans E Grossniklaus
Journal:  PLoS Comput Biol       Date:  2012-05-03       Impact factor: 4.475

4.  Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis.

Authors:  P L Penfold; J M Provis; F A Billson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

5.  Senile macular degeneration: the involvement of immunocompetent cells.

Authors:  P L Penfold; M C Killingsworth; S H Sarks
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

6.  Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.

Authors:  Chandrakumar Balaratnasingam; Jeffrey D Messinger; Kenneth R Sloan; Lawrence A Yannuzzi; K Bailey Freund; Christine A Curcio
Journal:  Ophthalmology       Date:  2017-01-30       Impact factor: 12.079

7.  Comparison of adaptive optics scanning light ophthalmoscopic fluorescein angiography and offset pinhole imaging.

Authors:  Toco Y P Chui; Michael Dubow; Alexander Pinhas; Nishit Shah; Alexander Gan; Rishard Weitz; Yusufu N Sulai; Alfredo Dubra; Richard B Rosen
Journal:  Biomed Opt Express       Date:  2014-03-13       Impact factor: 3.732

8.  Angiogenesis in early choroidal neovascularization secondary to age-related macular degeneration.

Authors:  M C Killingsworth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-06       Impact factor: 3.117

Review 9.  Clinical characteristics and current treatment of age-related macular degeneration.

Authors:  Yoshihiro Yonekawa; Ivana K Kim
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-03       Impact factor: 6.915

Review 10.  Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.

Authors:  Christine A Curcio; Mark Johnson; Jiahn-Dar Huang; Martin Rudolf
Journal:  Prog Retin Eye Res       Date:  2009-08-19       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.